SiriusPoint (SPNT) Investor presentation summary

Strategic highlights and business overview

• Focus on specialty underwriting with a diverse, low-volatility portfolio targeting a 12-15% ROE across the cycle.

• Upgraded to 'A' financial strength ratings by S&P, AM Best, and Fitch in 2026, reflecting improved risk profile.

• Robust balance sheet with $3.0bn capitalization, $6.3bn investments, and a 239% Bermuda Solvency Capital Ratio.

• Active capital management, returning $295m to shareholders YTD, including $51m in Q2'26 share repurchases.

• Consistent outperformance of core portfolio, with HY 26 Core Operating ROE at 16.2%, above target range.

Financial performance and results

• Q2'26 gross written premium up 6% YoY to $982m; net written premium up 1% to $710m.

• Q2'26 operating net income of $79m and operating EPS of $0.67; book value per share (ex. AOCI) up 3% to $19.48.

• HY 26 gross written premium up 3% to $1.99bn; operating net income up 19% YoY to $165m.

• HY 26 operating EPS of $1.37, diluted book value per share (ex. AOCI) up 8% YTD.

• Strong investment results with $151m total investment result and $66m net investment income in Q2'26.

Underwriting and portfolio management

• Core combined ratio of 91.4% in Q2'26 and 90.1% for HY 26, reflecting disciplined underwriting.

• Insurance & Services segment GWP grew 15% in Q2'26, while Reinsurance GWP declined 9% due to disciplined risk selection.

• Highly diversified portfolio by product, geography, and distribution channel; Accident & Health is the largest segment at 27% of GWP.

• Low volatility underwriting portfolio with combined ratio volatility of 2.6%, outperforming market average.

• Deliberate actions have reduced catastrophe loss ratio to 0.8% in Q2'26, among the lowest in peer group.